Advanced search
Publication Cover
Leukemia & Lymphoma Volume 54, 2013 - Issue 9
Submit an article Journal homepage
457
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Biologically defined risk groups can be used to define the impact of thalidomide maintenance therapy in newly diagnosed multiple myeloma

Annamaria BrioliHaemato-Oncology Research Unit, Division of Molecular Pathology, The Institute of Cancer Research, London, UK;Istituto di Ematologia Seràgnoli, Università degli Studi di Bologna, Policlinico S. Orsola-Malpighi, Bologna, Italy
,
Martin F. KaiserHaemato-Oncology Research Unit, Division of Molecular Pathology, The Institute of Cancer Research, London, UK
,
Charlotte PawlynHaemato-Oncology Research Unit, Division of Molecular Pathology, The Institute of Cancer Research, London, UK
,
Ping WuHaemato-Oncology Research Unit, Division of Molecular Pathology, The Institute of Cancer Research, London, UK
,
Walter M. GregoryClinical Trials Research Unit, University of Leeds, Leeds, UK
,
Roger OwenSt James's University Hospital, Leeds, UK
,
Fiona M. RossWessex Regional Genetics Laboratory, University of Southampton, Salisbury, UK
,
Graham H. JacksonHaematology Department, University of Newcastle, Newcastle-upon-Tyne, UK
,
Michele CavoIstituto di Ematologia Seràgnoli, Università degli Studi di Bologna, Policlinico S. Orsola-Malpighi, Bologna, Italy
,
Faith E. DaviesHaemato-Oncology Research Unit, Division of Molecular Pathology, The Institute of Cancer Research, London, UK
&
Gareth J. MorganHaemato-Oncology Research Unit, Division of Molecular Pathology, The Institute of Cancer Research, London, UKCorrespondence[email protected]
 show all
Pages 1975-1981 | Received 12 Oct 2012, Accepted 17 Dec 2012, Published online: 23 Jan 2013

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Eli Muchtar, Hila Magen & Morie A. Gertz. (2017) High-risk multiple myeloma: a multifaceted entity, multiple therapeutic challenges. Leukemia & Lymphoma 58:6, pages 1283-1296.
Read now

Articles from other publishers (12)

Leela Krishna Vamsee Miriyala & Deepti Avasthi. (2021) Cutaneous Multiple Myeloma. Cureus.
Crossref
Sarah Brown, Debbie Sherratt, Samantha Hinsley, Louise Flanagan, Sadie Roberts, Katrina Walker, Andrew Hall, Guy Pratt, Christina Messiou, Matthew Jenner & Martin Kaiser. (2021) MUK nine OPTIMUM protocol: a screening study to identify high-risk patients with multiple myeloma suitable for novel treatment approaches combined with a phase II study evaluating optimised combination of biological therapy in newly diagnosed high-risk multiple myeloma and plasma cell leukaemia . BMJ Open 11:3, pages e046225.
Crossref
Rowan Kuiper, Sonja ZweegmanMark van DuinMartin H. van Vliet, Erik H. van BeersBelinda DumeeMichael VermeulenJasper KoendersBronno van der HoltHeleen Visser-WisselaarMarkus Hansson, Annette W. G. van der VeldenH. Berna BeverlooMarian Stevens-Kroef, Mark-David Levin, Annemiek BroijlAnders Waage & Pieter Sonneveld. (2020) Prognostic and predictive performance of R-ISS with SKY92 in older patients with multiple myeloma: the HOVON-87/NMSG-18 trial. Blood Advances 4:24, pages 6298-6309.
Crossref
Wee Joo Chng & P. Leif Bergsagel. 2019. Molecular Hematology 4e. Molecular Hematology 4e 121 130 .
P. Sonneveld, H. Einsele, A. M. Brioli & M. Cavo. 2018. Multiple Myeloma and Other Plasma Cell Neoplasms. Multiple Myeloma and Other Plasma Cell Neoplasms 29 60 .
J R Jones, D A Cairns, W M Gregory, C Collett, C Pawlyn, R Sigsworth, A Striha, R Henderson, M F Kaiser, M Jenner, G Cook, N H Russell, C Williams, G Pratt, B Kishore, J Lindsay, M T Drayson, F E Davies, K D Boyd, R G Owen, G H Jackson & G J Morgan. (2016) Second malignancies in the context of lenalidomide treatment: an analysis of 2732 myeloma patients enrolled to the Myeloma XI trial. Blood Cancer Journal 6:12, pages e506-e506.
Crossref
Ho Sup Lee, Chang-Ki Min, Je-Jung Lee, Kihyun Kim, Seok Jin Kim, Dok Hyun Yoon, Hyeon-Seok Eom, Hyewon Lee, Won Sik Lee, Ho-Jin Shin, Ji Hyun Lee, Yong Park, Jae-Cheol Jo, Young Rok Do, Yeung-Chul Mun & Mark Hong Lee. (2016) The clinical impact of thalidomide maintenance after autologous stem cell transplantation in patients with newly diagnosed multiple myeloma in real clinical practice of Korea. Annals of Hematology 95:6, pages 911-919.
Crossref
James Wang, Kyle A. Udd, Aleksandra Vidisheva, Regina A. Swift, Tanya M. Spektor, Eric Bravin, Emad Ibrahim, Jonathan Treisman, Mohammed Masri & James R. Berenson. (2016) Low serum vitamin D occurs commonly among multiple myeloma patients treated with bortezomib and/or thalidomide and is associated with severe neuropathy. Supportive Care in Cancer.
Crossref
Michelle Dolan. 2016. Plasma Cell Neoplasms. Plasma Cell Neoplasms 79 99 .
Anne Marie Stoppa, Diane Coso, Guillemette Fouquet & Xavier Leleu. (2015) Consolidation and maintenance in de novo first-line multiple myeloma with modern agents . International Journal of Hematologic Oncology 4:1, pages 9-22.
Crossref
N. Rabin, M. Lai, G. Pratt, G. Morgan, J. Snowden, J. Bird, G. Cook, S. Bowcock, R. Owen, K. Yong, A. Wechalaker, E. Low & F. Davies. (2014) United Kingdom Myeloma Forum position statement on the use of consolidation and maintenance treatment in myeloma. International Journal of Laboratory Hematology 36:6, pages 665-675.
Crossref
Annamaria Brioli, Lorenzo Melchor, Michele Cavo & Gareth J. Morgan. (2014) The impact of intra-clonal heterogeneity on the treatment of multiple myeloma. British Journal of Haematology 165:4, pages 441-454.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.